{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Albumin+infusion+%2825%25+albumin%29&page=2", "query": { "intervention": "Albumin infusion (25% albumin)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 32, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Albumin+infusion+%2825%25+albumin%29&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Albumin+infusion+%2825%25+albumin%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-10T21:20:56.928Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03283761", "title": "FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gastro-Esophageal Junction Adenocarcinoma", "Gastric Cancer" ], "interventions": [ { "name": "Nab-paclitaxel 150 mg/m^2", "type": "DRUG" }, { "name": "Oxaliplatin 85 mg/m^2", "type": "DRUG" }, { "name": "5-FU 1200 mg/m^2 x 2 D", "type": "DRUG" }, { "name": "Leucovorin 400 mg/m^2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Al B. Benson, III, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2017-09-21", "completion_date": "2023-01-16", "has_results": true, "last_update_posted_date": "2024-02-06", "last_synced_at": "2026-10-10T21:20:56.928Z", "location_count": 8, "location_summary": "Chicago, Illinois • Lake Forest, Illinois • Iowa City, Iowa + 4 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Lake Forest", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Lansing", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03283761" }, { "nct_id": "NCT00006046", "title": "Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Colorectal Cancer" ], "interventions": [ { "name": "monoclonal antibody hu3S193", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Ludwig Institute for Cancer Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2000-07-12", "completion_date": "2002-09-24", "has_results": true, "last_update_posted_date": "2023-10-04", "last_synced_at": "2026-10-10T21:20:56.928Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00006046" }, { "nct_id": "NCT01747408", "title": "Treatment of Subarachnoid Hemorrhage With Human Albumin", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Subarachnoid Hemorrhage" ], "interventions": [ { "name": "Human Albumin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 47, "start_date": "2006-06", "completion_date": "2011-05", "has_results": false, "last_update_posted_date": "2012-12-11", "last_synced_at": "2026-10-10T21:20:56.928Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01747408" }, { "nct_id": "NCT00798915", "title": "Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Glucose-dependent Insulinotropic Polypeptide (GIP)", "type": "DRUG" }, { "name": "Xenin-25", "type": "DRUG" }, { "name": "Glucose-dependent Insulinotropic Polypeptide plus Xenin-25", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 40, "start_date": "2008-12", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2018-05-03", "last_synced_at": "2026-10-10T21:20:56.928Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00798915" }, { "nct_id": "NCT00108355", "title": "Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Ascites", "Cirrhosis" ], "interventions": [ { "name": "Albumin", "type": "DRUG" }, { "name": "Intravenous Saline Infusion (Albumin placebo)", "type": "DRUG" }, { "name": "Midodrine", "type": "DRUG" }, { "name": "Oral tablet (Midodrine placebo)", "type": "DRUG" }, { "name": "Octreotide LAR", "type": "DRUG" }, { "name": "Saline injection (Octreotide LAR placebo)", "type": "DRUG" }, { "name": "Large Volume Paracentesis", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "US Department of Veterans Affairs", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 29, "start_date": "2003-12", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2014-03-06", "last_synced_at": "2026-10-10T21:20:56.928Z", "location_count": 1, "location_summary": "West Haven, Connecticut", "locations": [ { "city": "West Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00108355" }, { "nct_id": "NCT02754726", "title": "Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Untreated Metastatic Pancreatic Ductal Adenocarcinoma" ], "interventions": [ { "name": "Nivolumab", "type": "DRUG" }, { "name": "Albumin-bound paclitaxel", "type": "DRUG" }, { "name": "Paricalcitol", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "HonorHealth Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2016-04", "completion_date": "2024-03-22", "has_results": true, "last_update_posted_date": "2025-08-27", "last_synced_at": "2026-10-10T21:20:56.928Z", "location_count": 1, "location_summary": "Scottsdale, Arizona", "locations": [ { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02754726" }, { "nct_id": "NCT03410030", "title": "Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pancreatic Cancer", "Pancreas Cancer", "Pancreatic Adenocarcinoma Resectable", "Pancreatic Ductal Adenocarcinoma", "Pancreas Metastases" ], "interventions": [ { "name": "High Dose Ascorbic Acid 25 g/m^2", "type": "DRUG" }, { "name": "Nanoparticle Paclitaxel protein bound 125mg/m^2", "type": "DRUG" }, { "name": "Cisplatin 25mg/m^2", "type": "DRUG" }, { "name": "Gemcitabine 1000mg/m^2", "type": "DRUG" }, { "name": "High Dose Ascorbic Acid 37.5 g/m^2", "type": "DRUG" }, { "name": "High Dose Ascorbic Acid 56.25 g/m^2", "type": "DRUG" }, { "name": "High Dose Ascorbic Acid 75 g/m^2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "HonorHealth Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2017-12-15", "completion_date": "2023-09-06", "has_results": true, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-10-10T21:20:56.928Z", "location_count": 1, "location_summary": "Scottsdale, Arizona", "locations": [ { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03410030" }, { "nct_id": "NCT01951729", "title": "The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pre-diabetes" ], "interventions": [ { "name": "Control", "type": "DRUG" }, { "name": "Xenin-25 without atropine", "type": "DRUG" }, { "name": "GIP without atropine", "type": "DRUG" }, { "name": "Placebo with atropine", "type": "DRUG" }, { "name": "Xenin-25 with atropine", "type": "DRUG" }, { "name": "GIP with atropine", "type": "DRUG" }, { "name": "GIP plus Xenin-25 without atropine", "type": "DRUG" }, { "name": "GIP plus Xenin-25 with atropine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 15, "start_date": "2013-03-13", "completion_date": "2015-05", "has_results": false, "last_update_posted_date": "2018-05-25", "last_synced_at": "2026-10-10T21:20:56.928Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01951729" }, { "nct_id": "NCT00235495", "title": "Albumin in Acute Ischemic Stroke Trial", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ischemic Stroke" ], "interventions": [ { "name": "Albumin", "type": "BIOLOGICAL" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "83 Years", "sex": "ALL", "summary": "18 Years to 83 Years" }, "enrollment_count": 841, "start_date": "2006-06", "completion_date": "2013-02", "has_results": true, "last_update_posted_date": "2019-12-17", "last_synced_at": "2026-10-10T21:20:56.928Z", "location_count": 69, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Concord, California + 48 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Concord", "state": "California" }, { "city": "Mountain View", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00235495" }, { "nct_id": "NCT00409383", "title": "Abraxane and Temodar Plus Genasense in Advanced Melanoma", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Melanoma" ], "interventions": [ { "name": "Genasense® (oblimersen)", "type": "DRUG" }, { "name": "Abraxane® (paclitaxel protein-bound particles for injectable suspension)", "type": "DRUG" }, { "name": "Temodar® (temozolomide)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genta Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 28, "start_date": "2006-11", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2011-11-07", "last_synced_at": "2026-10-10T21:20:56.928Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00409383" } ] }